close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Home・Aandelen Lijst・Lyell Immunopharma Inc
Search

Lyell Immunopharma Inc

Gesloten

16.77 -3.29

Neutraal

Prijsupdate 14 nov 2025, 20:57 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

16.76

Max

17.04

Belangrijke statistieken

By Trading Economics

Inkomsten

9.5M

-43M

Verkoop

1K

8K

EPS

-2.89

Winstmarge

-533,550

Werknemers

300

EBITDA

11M

-43M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-17.31% downside

Dividenden

By Dow Jones

Volgende Winsten

19 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

136M

340M

Vorige openingsprijs

20.06

Vorige sluitingsprijs

16.77

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

0.4217 / 0.4691 Steun & Weerstand

Lyell Immunopharma Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 nov 2025, 17:45 UTC

Winsten
Belangrijke Marktbewegers

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

DJ

Lezen

14 nov 2025, 17:31 UTC

Winsten
Belangrijke Marktbewegers

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

DJ

Lezen

15 nov 2025, 18:03 UTC

Winsten

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- UPDATED -- WSJ

DJ

Lezen

15 nov 2025, 15:43 UTC

Winsten

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- WSJ

DJ

Lezen

15 nov 2025, 09:20 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

15 nov 2025, 09:20 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

DJ

Lezen

15 nov 2025, 00:08 UTC

Acquisities, Fusies, Overnames

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

DJ

Lezen

14 nov 2025, 23:56 UTC

Acquisities, Fusies, Overnames

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

DJ

Lezen

14 nov 2025, 23:02 UTC

Marktinformatie

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

DJ

Lezen

14 nov 2025, 22:35 UTC

Winsten
Acquisities, Fusies, Overnames

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

DJ

Lezen

14 nov 2025, 22:32 UTC

Acquisities, Fusies, Overnames

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

DJ

Lezen

14 nov 2025, 22:29 UTC

Winsten

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

DJ

Lezen

14 nov 2025, 22:00 UTC

Acquisities, Fusies, Overnames

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

DJ

Lezen

14 nov 2025, 21:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

14 nov 2025, 21:18 UTC

Acquisities, Fusies, Overnames

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

DJ

Lezen

14 nov 2025, 20:27 UTC

Marktinformatie

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

DJ

Lezen

14 nov 2025, 20:23 UTC

Marktinformatie

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

DJ

Lezen

14 nov 2025, 20:17 UTC

Acquisities, Fusies, Overnames

Several State Attorneys General Oppose Railroad Merger -- WSJ

DJ

Lezen

14 nov 2025, 19:29 UTC

Marktinformatie
Winsten

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

DJ

Lezen

14 nov 2025, 18:44 UTC

Marktinformatie
Winsten

Disney's Growth Now Hinges More on ESPN -- Market Talk

DJ

Lezen

14 nov 2025, 18:27 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

14 nov 2025, 18:27 UTC

Marktinformatie

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

DJ

Lezen

14 nov 2025, 18:20 UTC

Marktinformatie

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

DJ

Lezen

14 nov 2025, 17:20 UTC

Marktinformatie
Winsten

Auto & Transport Roundup: Market Talk

DJ

Lezen

14 nov 2025, 17:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

DJ

Lezen

14 nov 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

14 nov 2025, 16:51 UTC

Marktinformatie

Starbucks Gets Holiday Sales Lift -- Market Talk

DJ

Lezen

14 nov 2025, 16:48 UTC

Marktinformatie

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

DJ

Lezen

14 nov 2025, 16:38 UTC

Marktinformatie

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

DJ

Lezen

14 nov 2025, 16:30 UTC

Acquisities, Fusies, Overnames

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

Lyell Immunopharma Inc Prognose

Koersdoel

By TipRanks

-17.31% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 14 USD  -17.31%

Hoogste 20 USD

Laagste 10 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Lyell Immunopharma Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

3 ratings

1

Buy

1

Hold

1

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Lyell Immunopharma Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

0.4217 / 0.4691Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Weak Bearish Evidence

There is one bearish event.

Lange Termijn

No Evidence

There are no events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,023.96

↑ +0.31%

JNJ

Johnson and Johnson

196.01

↑ +0.34%

ABBV

AbbVie Inc

232.37

↓0%

UNH

UnitedHealth Group Inc

321.37

↓-3.25%

AZN

AstraZeneca PLC ADR

89.14

↑ +0.64%
help-icon Live chat